Cargando…
Non‐Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis
AIMS: Mutant transthyretin (ATTRm) amyloidosis is a systemic disease caused by the deposition of amyloid fibrils derived from mutated transthyretin. Although cardiac involvement impacts the prognosis of patients with ATTRm amyloidosis, the incidence of cardiac events, such as bradyarrhythmia, ventri...
Autores principales: | Hirakawa, Kyoko, Takashio, Seiji, Marume, Kyohei, Yamamoto, Masahiro, Hanatani, Shinsuke, Yamamoto, Eiichiro, Sakamoto, Kenji, Izumiya, Yasuhiro, Kaikita, Koichi, Oda, Seitaro, Utsunomiya, Daisuke, Shiraishi, Shinya, Ueda, Mitsuharu, Yamashita, Taro, Yamashita, Yasuyuki, Ando, Yukio, Tsujita, Kenichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352919/ https://www.ncbi.nlm.nih.gov/pubmed/30284755 http://dx.doi.org/10.1002/ehf2.12361 |
Ejemplares similares
-
Usefulness of automatic assessment for longitudinal strain to diagnose wild-type transthyretin amyloid cardiomyopathy
por: Usuku, Hiroki, et al.
Publicado: (2023) -
Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis
por: Takashio, Seiji, et al.
Publicado: (2017) -
Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild‐type transthyretin amyloid cardiomyopathy
por: Takashio, Seiji, et al.
Publicado: (2023) -
Correlation Between Cardiac Images, Biomarkers, and Amyloid Load in Wild‐Type Transthyretin Amyloid Cardiomyopathy
por: Morioka, Mami, et al.
Publicado: (2022) -
Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis
por: Oike, Fumi, et al.
Publicado: (2022)